PepsiCo Hasn't Been This Cheap Relative to Earnings in 6 Years. Here's Why That's the Signal to Buy.

PepsiCo is trading at about 17 times trailing earnings, its lowest valuation in roughly six years, after its shares fell about 20% since early 2024 and now sit 30% below their all-time high. North American beverage volume declined 2% year over year in Q3 2026, food volumes were flat, and analysts estimate 4% annual earnings growth over the next three to five years versus 8% for Coca-Cola. The article argues that the 4.3% dividend yield, planned $8.9 billion in 2026 dividends and buybacks, and Elliott Management's $4 billion stake support an upside case, while acknowledging execution and demand risks.

Analysis

The key debate is whether PepsiCo can trade lower prices for enough volume to offset near-term margin pressure. If price cuts lift unit demand and improve shelf velocity, fixed-cost leverage and better mix could make earnings recovery faster than current low-growth expectations imply. If consumers remain price-sensitive—or volume fails to respond—the company gives up price realization without repairing demand. That is the central falsifier, not the dividend yield.

Activist pressure is a potential catalyst over the next 1–3 months, but a narrower U.S. portfolio could also weaken cross-brand leverage at retailers and create execution costs. Watch for specific commitments on pricing, SKU rationalization, and North American volume; broad promises are not evidence of a turnaround. Coca-Cola may benefit at the margin if beverage buyers switch, but PEP’s food exposure makes KO an imperfect hedge. GLP-1 adoption is a plausible demand headwind, not yet proof of a durable category-wide decline.

Over 6–18 months, the upside case requires volume recovery without a sustained deterioration in operating profitability or cash generation. The dividend and buybacks can support returns, but they do not establish a hard floor if earnings expectations fall. The contrarian opportunity is that pessimism may already discount a slow reset; the risk is treating a low historical multiple as protection despite structurally weaker growth.

Key Decisions for Investors

• Consider a staged, modest PEP long for a 6–18 month horizon rather than buying solely on the valuation discount. Add only after reported North American volumes improve and profitability holds up; reduce or exit if volume remains weak while price/mix and operating performance deteriorate.
• Track the next earnings update and activist-related disclosures for measurable pricing, SKU, and cost actions. Treat stated plans as unverified until followed by volume and margin outcomes.
• Do not use KO as a simple short hedge against PEP: the businesses and growth profiles differ, and the relative trade may remain against PEP if its execution gap persists. Reassess only with current valuation, estimate revisions, and operating data for both companies.
• Falsify the recovery thesis if successive reports show no North American volume response to pricing changes, or if earnings guidance and cash generation weaken enough to put shareholder returns under pressure.